Results 211 to 220 of about 242,578 (255)

Upadacitinib for atopic dermatitis induced by secukinumab in patients with refractory ankylosing spondylitis:a case report. [PDF]

Front Immunol
Fang J, Pan S.
europepmc   +1 more source

Integrated Single-Cell Profiling Reveals TL1A as a Biomarker and Driver of Type 2 Inflammation via Macrophage-Dependent Immunoregulation in Asthma. [PDF]

Research (Wash D C)
Zhang J, Liu X, Qi Q, Pan Y, Zeng R, Qiao C, Xu C, Wang P, Shi S, Wang Y, Liu X, Dong L.   +11 more
europepmc   +1 more source

The role of JAK3 and TEC family kinases in vitiligo pathogenesis. [PDF]

Front Immunol
Passeron T, Seneschal J, Picardo M, Xiang L, Tanemura A, Winkler A, Telliez JB, Adiri R.   +7 more
europepmc   +1 more source

Integrating single-cell and spatial transcriptomics to decipher the neuro-immune microenvironment of breast cancer brain metastasis: a key regulatory axis, prognostic model, and drug discovery. [PDF]

Transl Cancer Res
Li J, Wu W, Lu J, Yang H, Leng Y, Lei B.
europepmc   +1 more source

Mitigating Teclistamab Toxicity: Prophylactic Tocilizumab and Timing of Immunoglobulin Replacement Therapy in a Nationwide Cohort

American Journal of Hematology, EarlyView.
Astrid Hundebøll Torpe, Jonathan Thorsen, Gustav Mathiasen, Katrine Fladeland Iversen, Sarah Farmer, Thomas Lund, Charlotte Toftmann Hansen, Lene Kongsgaard Nielsen, Nicolai Grønne Dahlager Jørgensen, Maja Ølholm Vase, Elena Manuela Teodorescu, Morten Salomo, Christina Wennerström, Tobias S. Slørdahl, Agoston Gyula Szabo   +14 more
wiley   +1 more source

Establishment of a New Interleukin-6(IL-6) Receptor Inhibitor Applicable to the Gene Therapy for IL-6-Dependent Tumor

Establishment of a New Interleukin-6(IL-6) Receptor Inhibitor Applicable to the Gene Therapy for IL-6-Dependent Tumor
openaire